investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Mizuki Nishino

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Trachea, bronchus and lung

Stephen Scwartz

EXPANDING SEER TO INCLUDE MOLECULAR PROFILING IN NON-SMALL CELL LUNG CANCER (NSCLC)

Trachea, bronchus and lung

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Deborah Morrison

Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction

Trachea, bronchus and lung

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology

Susan Bates

Investigation of the ABC Half-Transporter ABCG2

Trachea, bronchus and lung

Allan Balmain

The Role of the Kras4A Isoform in Epithelial Carcinogenesis

Trachea, bronchus and lung

Pathology

Michael J Holliday

Mapping and Controlling the Segmental Dynamic Networks of Cyclophilin A as they Relate to Enzymatic Function

Trachea, bronchus and lung

Pasi A Janne

Drug Resistance in Lung Cancer

Trachea, bronchus and lung